Unknown

Dataset Information

Real-World Comparisons of Low-Dose NOACs versus Standard-Dose NOACs or Warfarin on Efficacy and Safety in Patients with AF: A Meta-Analysis.


ABSTRACT:

Objective

We aimed to further investigate the efficacy and safety of low-dose NOACs by performing a meta-analysis of cohort studies.

Background

Meta-analyses of randomized controlled trials (RCTs) have demonstrated that low-dose non-vitamin K antagonist oral anticoagulants (NOACs) showed inferior efficacy compared with standard-dose NOACs, although they are still frequently prescribed for patients with atrial fibrillation (AF) in the clinical practice.

Methods

Cochrane Central Register of Controlled Trials (CENTRAL), Embase, and MEDLINE were systematically searched from the inception to September 9, 2021, for cohort studies that compared the efficacy and/or safety of low-dose NOACs in patients with AF. The primary outcomes were ischemic stroke and major bleeding, and

SUBMITTER: Li Z 

PROVIDER: S-EPMC9017587 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature